David M. Denton - 03 Mar 2026 Form 4 Insider Report for PFIZER INC (PFE)

Role: Chief Financial Officer & EVP
Signature: /s/ Shanice A. Reid, by power of atty, for David M. Denton
Issuer symbol: PFE
Transactions as of: 03 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2026, 17:26:54 UTC
Previous filing: 06 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Denton David M	Chief Financial Officer & EVP	66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK	/s/ Shanice A. Reid, by power of atty, for David M. Denton	05 Mar 2026	0001428718

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Award		+216,537		$0.000000^*	216,537	03 Mar 2026	Common Stock	216,537	$26.58	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.